Ctc LLC Pfizer Inc Transaction History

Ctc LLC

$3.06 Billion
Q2 2024

A detailed history of Ctc LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ctc LLC holds 690 shares of PFE stock, worth $18,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares

690

Previous 1,620 57.41%

Holding current value

$18,947

Previous $44,000 56.82%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $3.08 Million - $3.61 Million	-121,813 Reduced 30.84%	273,203 $7.64 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $4.74 Million - $5.45 Million	-183,203 Reduced 31.68%	395,016 $11 Million
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $7.59 Million - $9.86 Million	290,493 Added 100.96%	578,219 $16.6 Million
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $3.61 Million - $4.22 Million	-112,407 Reduced 28.09%	287,726 $9.54 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $13.8 Million - $15.9 Million	381,613 Added 2060.55%	400,133 $14.7 Million
Q1 2023 May 22, 2023	BUY	$39.39 - $51.28 $729,502 - $949,705	18,520 New	18,520 $755,000
Q2 2022 Jul 07, 2022	SELL	$46.53 - $55.17 $9.28 Million - $11 Million	-199,343 Reduced 50.6%	194,629 $10.2 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $44.4 Million - $55 Million	-971,054 Reduced 71.14%	393,972 $20.4 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $33.6 Million - $49.9 Million	813,977 Added 147.71%	1,365,026 $80.6 Million
Q3 2021 Nov 16, 2021	SELL	$39.25 - $50.42 $21.6 Million - $27.8 Million	-551,049 Reduced 50.0%	551,049 $23.7 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $43.3 Million - $55.6 Million	1,102,098 New	1,102,098 $47.4 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ctc LLC with notifications on news.

Account